MMP9 | Matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | ![](/images/1238/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/63909/152372_A_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
MTOR | Mechanistic target of rapamycin (serine/threonine kinase) | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| ![](/images/5057/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/5057/18352_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
MTR | 5-methyltetrahydrofolate-homocysteine methyltransferase | Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Expressed in all |
MUT | Methylmalonyl CoA mutase | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted intracellular proteins
| | ![](/images/35971/if_selected_60x60.jpg) | ![](/images/35971/145837_A_4_7_selected_60x60.jpg) | ![](/images/35971/74640_B_8_3_rna_selected_60x60.jpg) | Expressed in all |
NNMT | Nicotinamide N-methyltransferase | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| ![](/images/59180/ihc_selected_60x60.jpg) | ![](/images/59180/1184_C12_2_selected_60x60.jpg) | ![](/images/59180/ihc_cell_selected_60x60.jpg) | ![](/images/59180/132923_B_8_4_rna_selected_60x60.jpg) | Expressed in all |
NOS2 | Nitric oxide synthase 2, inducible | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| ![](/images/2014/5433_A_4_3_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/2014/5425_B_8_8_rna_selected_60x60.jpg) | Group enriched |
NOS3 | Nitric oxide synthase 3 (endothelial cell) | Cancer-related genes Cytoskeleton related proteins Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | | ![](/images/2168/5988_B_9_2_rna_selected_60x60.jpg) | Tissue enriched |
NPR1 | Natriuretic peptide receptor 1 | Enzymes FDA approved drug targets Predicted membrane proteins
| ![](/images/31087/ihc_selected_60x60.jpg) | ![](/images/31087/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/31087/71781_B_8_4_rna_selected_60x60.jpg) | Tissue enhanced |
NPR2 | Natriuretic peptide receptor 2 | Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| ![](/images/11977/ihc_selected_60x60.jpg) | ![](/images/11977/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/11977/28490_B_7_3_rna_selected_60x60.jpg) | Mixed |
NTRK1 | Neurotrophic tyrosine kinase, receptor, type 1 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins
| ![](/images/35799/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/35799/129188_B_9_1_rna_selected_60x60.jpg) | Tissue enriched |
PAH | Phenylalanine hydroxylase | Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | ![](/images/28407/1399_C5_1_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/28407/155687_B_8_6_rna_selected_60x60.jpg) | Group enriched |
PDE10A | Phosphodiesterase 10A | Enzymes FDA approved drug targets Predicted intracellular proteins
| ![](/images/45998/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/47200/ihc_cell_selected_60x60.jpg) | ![](/images/47200/107459_B_8_7_rna_selected_60x60.jpg) | Tissue enhanced |
PDE3A | Phosphodiesterase 3A, cGMP-inhibited | Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| ![](/images/14492/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/14492/34301_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
PDE4A | Phosphodiesterase 4A, cAMP-specific | Enzymes FDA approved drug targets Predicted intracellular proteins
| ![](/images/43310/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/43310/114127_B_8_3_rna_selected_60x60.jpg) | Expressed in all |
PDE4B | Phosphodiesterase 4B, cAMP-specific | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| ![](/images/3005/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/3005/9038_B_8_4_rna_selected_60x60.jpg) | Mixed |
PDE4C | Phosphodiesterase 4C, cAMP-specific | Enzymes FDA approved drug targets Predicted intracellular proteins
| ![](/images/48975/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/48975/ihc_cell_selected_60x60.jpg) | ![](/images/48975/114795_B_9_1_rna_selected_60x60.jpg) | Mixed |
PDE4D | Phosphodiesterase 4D, cAMP-specific | Cytoskeleton related proteins Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| ![](/images/45895/ihc_selected_60x60.jpg) | ![](/images/45895/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/45895/102563_B_7_7_rna_selected_60x60.jpg) | Expressed in all |
PDE5A | Phosphodiesterase 5A, cGMP-specific | Enzymes FDA approved drug targets Predicted intracellular proteins
| | ![](/images/4729/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/4729/13328_A_3_7_rna_selected_60x60.jpg) | Expressed in all |
PDE7A | Phosphodiesterase 7A | Enzymes FDA approved drug targets Predicted intracellular proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/27340/ihc_cell_selected_60x60.jpg) | ![](/images/27340/57247_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
PDE7B | Phosphodiesterase 7B | Enzymes FDA approved drug targets Predicted intracellular proteins
| ![](/images/23967/ihc_selected_60x60.jpg) | ![](/images/23967/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/23967/53087_B_8_2_rna_selected_60x60.jpg) | Mixed |
PDE8A | Phosphodiesterase 8A | Enzymes FDA approved drug targets Predicted intracellular proteins
| ![](/images/7722/ihc_selected_60x60.jpg) | ![](/images/7722/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/7722/20694_B_8_2_rna_selected_60x60.jpg) | Expressed in all |
PDE8B | Phosphodiesterase 8B | Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | ![](/images/36912/1054_B12_1_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/36912/79380_A_3_2_rna_selected_60x60.jpg) | Tissue enriched |
PDGFRA | Platelet-derived growth factor receptor, alpha polypeptide | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| ![](/images/18143/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/18143/43111_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
PDGFRB | Platelet-derived growth factor receptor, beta polypeptide | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | ![](/images/28499/if_selected_60x60.jpg) | | ![](/images/3842/10176_B_9_3_rna_selected_60x60.jpg) | Mixed |
PDXK | Pyridoxal (pyridoxine, vitamin B6) kinase | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| ![](/images/30196/ihc_selected_60x60.jpg) | | | ![](/images/30196/65230_B_5_2_rna_selected_60x60.jpg) | Expressed in all |
PLA2G1B | Phospholipase A2, group IB (pancreas) | Candidate cardiovascular disease genes Enzymes FDA approved drug targets Predicted intracellular proteins Predicted secreted proteins RAS pathway related proteins
| | ![](/images_static/na_center.gif) | ![](/images/60803/ihc_cell_selected_60x60.jpg) | ![](/images/60803/135493_A_2_5_rna_selected_60x60.jpg) | Tissue enriched |
PLA2G2A | Phospholipase A2, group IIA (platelets, synovial fluid) | Enzymes FDA approved drug targets Predicted secreted proteins RAS pathway related proteins
| ![](/images/15236/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/15236/41161_A_2_3_rna_selected_60x60.jpg) | Tissue enhanced |
PLA2G4A | Phospholipase A2, group IVA (cytosolic, calcium-dependent) | Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | ![](/images/10050/28034_B_9_2_rna_selected_60x60.jpg) | Mixed |
PLA2G6 | Phospholipase A2, group VI (cytosolic, calcium-independent) | Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins RAS pathway related proteins
| ![](/images/1171/ihc_selected_60x60.jpg) | ![](/images/1171/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/1171/3846_B_7_4_rna_selected_60x60.jpg) | Expressed in all |
PLAT | Plasminogen activator, tissue | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | ![](/images/3412/if_selected_60x60.jpg) | ![](/images/3412/ihc_cell_selected_60x60.jpg) | ![](/images/3412/10705_B_9_2_rna_selected_60x60.jpg) | Mixed |
PLAU | Plasminogen activator, urokinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| ![](/images/8719/ihc_selected_60x60.jpg) | ![](/images/8719/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/8719/22331_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
PLG | Plasminogen | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/668/ihc_cell_selected_60x60.jpg) | ![](/images/668/1156_B_8_5_rna_selected_60x60.jpg) | Tissue enriched |
PNLIP | Pancreatic lipase | Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/62430/143747_A_3_7_selected_60x60.jpg) | ![](/images/62430/143699_B_5_4_rna_selected_60x60.jpg) | Tissue enriched |
PNP | Purine nucleoside phosphorylase | Cytoskeleton related proteins Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| ![](/images/1625/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | | ![](/images/1625/7078_B_9_4_rna_selected_60x60.jpg) | Expressed in all |
POLA1 | Polymerase (DNA directed), alpha 1, catalytic subunit | Enzymes FDA approved drug targets Predicted intracellular proteins
| | | ![](/images/2947/ihc_cell_selected_60x60.jpg) | ![](/images/2947/8235_A_7_4_rna_selected_60x60.jpg) | Expressed in all |
POLB | Polymerase (DNA directed), beta | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | ![](/images/49104/if_selected_60x60.jpg) | ![](/images/49104/140706_A_1_7_selected_60x60.jpg) | ![](/images/11616/26615_B_8_5_rna_selected_60x60.jpg) | Expressed in all |
POLE | Polymerase (DNA directed), epsilon, catalytic subunit | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Expressed in all |
POLE2 | Polymerase (DNA directed), epsilon 2, accessory subunit | Enzymes FDA approved drug targets Predicted intracellular proteins
| ![](/images/27555/ihc_selected_60x60.jpg) | | ![](/images/27555/ihc_cell_selected_60x60.jpg) | ![](/images/27555/58602_B_8_1_rna_selected_60x60.jpg) | Mixed |
POLE3 | Polymerase (DNA directed), epsilon 3, accessory subunit | Enzymes FDA approved drug targets Predicted intracellular proteins
| ![](/images/47945/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/47945/110030_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
POLE4 | Polymerase (DNA-directed), epsilon 4, accessory subunit | Enzymes FDA approved drug targets Predicted intracellular proteins
| ![](/images/71815/154981_A_7_5_selected_60x60.jpg) | ![](/images/54979/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/71815/154980_B_8_5_rna_selected_60x60.jpg) | Expressed in all |
PRDX5 | Peroxiredoxin 5 | Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted intracellular proteins
| | | | ![](/images/8661/22812_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
PRKAA1 | Protein kinase, AMP-activated, alpha 1 catalytic subunit | Enzymes FDA approved drug targets Predicted intracellular proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/64946/144083_B_9_5_rna_selected_60x60.jpg) | Expressed in all |
PROC | Protein C (inactivator of coagulation factors Va and VIIIa) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/5550/16154_B_9_2_rna_selected_60x60.jpg) | Tissue enriched |
PSMB1 | Proteasome (prosome, macropain) subunit, beta type, 1 | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | ![](/images/29635/64707_B_9_3_rna_selected_60x60.jpg) | Expressed in all |
PSMB10 | Proteasome (prosome, macropain) subunit, beta type, 10 | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | ![](/images/30225/157730_A_2_8_selected_60x60.jpg) | ![](/images/30225/69734_B_9_5_rna_selected_60x60.jpg) | Expressed in all |
PSMB2 | Proteasome (prosome, macropain) subunit, beta type, 2 | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| ![](/images/26322/ihc_selected_60x60.jpg) | | ![](/images/26324/ihc_cell_selected_60x60.jpg) | ![](/images/26322/56170_B_7_3_rna_selected_60x60.jpg) | Expressed in all |
PSMB5 | Proteasome (prosome, macropain) subunit, beta type, 5 | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| ![](/images/49518/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/49518/112212_B_8_6_rna_selected_60x60.jpg) | Expressed in all |
PSMB8 | Proteasome (prosome, macropain) subunit, beta type, 8 | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | ![](/images/50327/784_D12_2_selected_60x60.jpg) | | ![](/images/50327/118546_B_9_4_rna_selected_60x60.jpg) | Expressed in all |
PSMB9 | Proteasome (prosome, macropain) subunit, beta type, 9 | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | ![](/images/15180/155552_A_8_3_selected_60x60.jpg) | ![](/images/15180/142201_B_2_4_rna_selected_60x60.jpg) | Expressed in all |
PTGIS | Prostaglandin I2 (prostacyclin) synthase | Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| ![](/images/9517/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/9517/28026_B_9_3_rna_selected_60x60.jpg) | Mixed |